1. Market Research
  2. > Biotechnology
  3. > Genomics Market Trends

Vital Signs - The Analyst's Perspective - March 2015 Issue

  • April 2015
  • 7 pages
  • Frost & Sullivan
Report ID: 2861526

Summary

Table of Contents

This issue of Vital Signs, released on April 3, 2015, discusses next-generation sequencing bioinformatics partnerships, FDA approval of Novartis's ZARXIO, 23andMe's foray into drug development, and Johnson & Johnson's sale of Cordis to Cardinal Health.

NGS Bioinformatics Partnerships Heat Up

Source: Cartagenia and Tute Genomics, March 17, 2015
On March 17, two announcements emerged concerning next-generation sequencing (NGS) informatics companies teaming up to provide complete workflows. DNAnexus and Tute Genomics joined forces, while Cartegenia and N-of-One will integrate their offerings as well. DNAnexus and Tute Genomics have teamed up to provide an integrated solution for upstream primary analyses and downstream interpretation along the NGS bioinformatics workflow. DNAnexus, based in Mountain View, Calif., provides a configurable cloud-based platform for storage, computing, and NGS primary and secondary data analysis. Tute Genomics, based in Provo, Utah, provides a cloud-based solution for genome annotation and clinical interpretation and reporting.

The combined offering streamlines data transfer between the two offerings so end users can easily transfer variant data from DNAnexus to Tute’s platform for downstream analysis. Cartegnia, based in Cambridge, Mass., offers its Bench Lab NGS platform, which manages NGS data, performs variant calling, and puts variants into patient-related information and phenotypic context. N-of-One provides clinical interpretation services of NGS data. The combined offering is aimed at pathology labs, allowing them to
integrate N-of-One’s genomic and tumor intreprations into their Bench Lab NGS platforms.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers
Predictive Genetic Testing And Consumer/Wellness Genomics Market By Application (Cancer, Diabetic Screening, Parkinsonism, Cardiovascular, Orthopedic & Musculoskeletal, Nutria Genetics, Skin & Metabolism Genetics) And Trend Analysis From 2013 To 2025

Predictive Genetic Testing And Consumer/Wellness Genomics Market By Application (Cancer, Diabetic Screening, Parkinsonism, Cardiovascular, Orthopedic & Musculoskeletal, Nutria Genetics, Skin & Metabolism Genetics) And Trend Analysis From 2013 To 2025

  • $ 4950
  • Industry report
  • January 2017
  • by Grand View Research

The global predictive genetic testing & consumer/wellness genomics market is anticipated to reach USD 4.6 billion by 2025, according to a new report by Grand View Research, Inc. Key drivers attributing ...

CRISPR And CRISPR-Associated (Cas) Genes Market Analysis By Product (Vector-Based & DNA-Free Cas), By Application (Genome Engineering, Disease Models, Functional Genomics), By End-Use And Segment Forecasts, 2014 - 2025

CRISPR And CRISPR-Associated (Cas) Genes Market Analysis By Product (Vector-Based & DNA-Free Cas), By Application (Genome Engineering, Disease Models, Functional Genomics), By End-Use And Segment Forecasts, 2014 - 2025

  • $ 4950
  • Industry report
  • January 2017
  • by Grand View Research

The Clustered regularly interspaced short palindromic repeats CRISPR and CRISPR-associated (Cas) genes market is anticipated to reach USD 4.09 billion by 2025, according to a new report by Grand View Research, ...

Global Pharmacogenomics Partnering Terms and Agreements 2010 to 2017

Global Pharmacogenomics Partnering Terms and Agreements 2010 to 2017

  • $ 2995
  • Industry report
  • February 2017
  • by Currentpartnering

Summary The Global Pharmacogenomics Partnering Terms & Agreements 2010 to 2017 report provides comprehensive understanding and unprecedented access to the pharmacogenomics partnering deals and agreements ...


Download Unlimited Documents from Trusted Public Sources

Genomics Industry in New Zealand

  • May 2017
    8 pages
  • Genomics  

  • New Zealand  

View report >

Genomics Industry in Africa

  • May 2017
    7 pages
  • Genomics  

  • Africa  

View report >

DNA Industry in the US

  • May 2017
    13 pages
  • DNA  

    Genome Sequenci...  

  • United States  

    Puerto Rico  

    North America  

View report >

Dna Industry

25 days ago

Related Market Segments :

Genomics
Bioinformatic

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.